Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 19.18

From 52W high−34.11%

Volume7.09M

Market capCNY 12.18B

P/E (TTM)32.0x

P/S (TTM)9.4x

Div yield0.77%

Key dataSep 18, 2026

Open

CNY 19.18

From 52W high

−34.11%

Volume

7.09M

Market cap

CNY 12.18B

ValuationView details →

P/E (Fwd)

22.9x

EV/EBITDA

19.3x

P/E (TTM)

32.0x

RSI (14)

32.4

MomentumView details →

1D Return

−5.64%

YTD Return

−31.39%

ValuationView details →

P/E (Fwd)

22.9x

P/E (TTM)

32.0x

EV/EBITDA

19.3x

EV/Sales

8.7x

P/S (TTM)

9.4x

P/B (TTM)

4.6x

ProfitabilityView details →

Gross Margin

95.34%

Net Margin

39.18%

EBITDA Margin

45.10%

ROE (TTM)

15.55%

ROA (TTM)

14.50%

Asset Turnover

0.37x

GrowthView details →

Revenue YoY

+15.91%

EPS YoY

+35.20%

FCF YoY

+55.07%

Revenue CAGR 3Y

+5.84%

EPS CAGR 3Y

+2.99%

EBITDA YoY

—

MomentumView details →

1D Return

−5.64%

YTD Return

−31.39%

1Y Return

−32.32%

RSI (14)

32.4

vs 50D SMA

−16.17%

vs 200D SMA

−23.81%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

26.14x

Quick Ratio

25.34x

Div Yield

0.77%

Div Rate

CNY 0.15

Div Growth 1Y

+18.92%

EarningsView details →

EPS (Actual)

CNY 0.18

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.16

Avg Surprise (4Q)

—

Rev Surprise

0.00%

Financials snapshotView financials →

Revenue (TTM)

1.09B

Net Income (TTM)

425.83M

Op. CF (TTM)

392.36M

Next earningsOct 28, 2026 →

Latest newsMore news →

On September 8, 2026, Wolwo Bio-Pharmaceutical announced that due to divorce property division, its actual controller changed from Hu Gengxi and Yanni Chen to Yanni Chen alone, with Hu Gengxi's direct shares and his stake in Mingchen Investment transferred to family members.12d ago

On September 8, 2026, Hu Gengxi resigned as chairman, director, and legal representative of Wolwo Bio-Pharmaceutical, effective immediately, and will no longer hold any position in the company.12d ago

Similar companies

恒帅股份300969.SZ 航天智装300455.SZ 光力科技300480.SZ 奥瑞金002701.SZ 美格智能002881.SZ 容大感光300576.SZ Find similar companies →

Latest newsMore news →

On September 8, 2026, Wolwo Bio-Pharmaceutical announced that due to divorce property division, its actual controller changed from Hu Gengxi and Yanni Chen to Yanni Chen alone, with Hu Gengxi's direct shares and his stake in Mingchen Investment transferred to family members.12d ago On September 8, 2026, Hu Gengxi resigned as chairman, director, and legal representative of Wolwo Bio-Pharmaceutical, effective immediately, and will no longer hold any position in the company.12d ago On September 8, 2026, Hu Gengxi and YANNI CHEN dissolved their marriage and split property, resulting in Hu Gengxi holding 8.35% of Myhealth Biotechnology, becoming a single shareholder above 5%.12d ago